← SynDRA

TEGOBUVIR

SynDRA canonical compound SYN0028799 — structure-anchored drug synonym record

All known targets

• HCV NS5B

Mechanisms of action (all sources)

• HCV inhibitor
• protease inhibitor
• HCV NS5B INHIBITOR

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

• KCNH2
• HDAC6

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

• CP2C9
• CP3A7

Cross-references

• PubChem CID: 23649154
• ChEMBL: CHEMBL1957287
• DrugBank: DB11852
• KEGG: D09971
• TTD: D09RVI
• LINCS BRD: BRD-K26701552

Synonyms

• GS-333126
• GS-9190
• UNII-5NOK5X389M
• 5-((6-(2,4-bis(Trifluoromethyl)phenyl)pyridazin-3-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine
• 5NOK5X389M
• GS 9190
• GS 333126
• W-204340
• 5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-;5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-
• Tegobuvir [USAN:INN]
• Tegobuvir (USAN/INN)
• SCHEMBL496778
• CHEMBL1957287
• DTXSID80142917
• tegobuvirum
• RefChem:932660
• DTXCID8065408
• MFCD18251457
• C25H14F7N5
• Tegobuvir [INN]
• TEGOBUVIR [USAN]
• TEGOBUVIR [WHO-DD]
• orb1307687
• SCHEMBL29632593
• XBEQSQDCBSKCHJ-UHFFFAOYSA-N
• BDBM50461671
• EX-A11183
• AKOS015949531
• CS-0672
• SB16972
• NCGC00378881-01
• AS-74871
• HY-10544
• DB-349549
• NS00073275
• Tegobuvir (GS-9190; GS 333126)?
• D09971
• T17029